Dr. Kira Sheinerman is a Managing Director of Investment Banking at H.C. Wainwright and co-founder of DiamiR Biosciences. She brings deep expertise in healthcare fundraising, strategic advisory, and operations. Dr. Sheinerman has served on multiple boards and industry initiatives, including the Boyce Thompson Institute and the Alzheimer’s Association Business Consortium. She holds a PhD in Biomedical Sciences from Mount Sinai School of Medicine and an Honors MBA from Baruch College.
